| |
Article Title |
Author(s) |
Type |
Pages |
|
Pharmacogenomics in Cancer Chemotherapy
8 March 2006 (Vol. 234 | No. 1 | Page 1)
|
Toshihisa Ishikawa
|
Editorial
|
1-1
|
|
Featuring the Special Issue Editor
8 March 2006 (Vol. 234 | No. 1 | Pages 2-3)
|
Toshihisa Ishikawa
|
Editorial
|
2-3
|
|
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
8 March 2006 (Vol. 234 | No. 1 | Pages 4-33)
|
Reinhold Kerb
|
Short survey
|
4-33
|
|
Role of copper transporters in the uptake and efflux of platinum containing drugs
8 March 2006 (Vol. 234 | No. 1 | Pages 34-39)
|
Roohangiz Safaei
|
Short survey
|
34-39
|
|
Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response
8 March 2006 (Vol. 234 | No. 1 | Pages 40-50)
|
Morimasa Wada
|
Short survey
|
40-50
|
|
MRP2 and 3 in health and disease
8 March 2006 (Vol. 234 | No. 1 | Pages 51-61)
|
P. Borst,
N. Zelcer,
K. van de Wetering
|
Short survey
|
51-61
|
|
The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology
8 March 2006 (Vol. 234 | No. 1 | Pages 62-72)
|
Judit Cervenak,
Hajnalka Andrikovics,
Csilla Özvegy-Laczka,
Attila Tordai,
Katalin Német,
András Váradi,
Balázs Sarkadi
et al.
|
Short survey
|
62-72
|
|
Functional SNPs of the breast cancer resistance protein ‐ therapeutic effects and inhibitor development
8 March 2006 (Vol. 234 | No. 1 | Pages 73-80)
|
Kae Yanase,
Satomi Tsukahara,
Junko Mitsuhashi,
Yoshikazu Sugimoto
|
Short survey
|
73-80
|
|
Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer
8 March 2006 (Vol. 234 | No. 1 | Pages 81-89)
|
Hiroshi Nakagawa,
Hikaru Saito,
Yoji Ikegami,
Sachiko Aida-Hyugaji,
Seigo Sawada,
Toshihisa Ishikawa
et al.
|
Short survey
|
81-89
|
|
Role of pharmacogenetics in irinotecan therapy
8 March 2006 (Vol. 234 | No. 1 | Pages 90-106)
|
Floris A. de Jong,
Maja J.A. de Jonge,
Jaap Verweij,
Ron H.J. Mathijssen
|
Short survey
|
90-106
|
